#ESCCongress: Mortality Benefits With High-Dose Influenza Vaccines
- Cardio
- 27/08/2022
Findings from the DANFLU-1 trial presented at the ESC Congress in Barcelona show that high-dose influenza vaccination in older adults reduces the risk of death by 49% and the incidence of hospitalisa
READ MORE